Global Lyme Disease Testing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Lyme Disease Testing market size will reach 259.16 Million USD in 2025 and is projected to reach 408.32 Million USD by 2032, with a CAGR of 6.71% (2025-2032). Notably, the China Lyme Disease Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Lyme disease testing refers to the diagnostic procedures used to detect the presence of Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) and the Western blot test. The EIA is typically used as a screening test and if positive or equivocal, the Western blot test is performed to confirm the diagnosis. These tests detect specific antibodies against the Lyme disease bacteria. However, it is essential to note that the accuracy of these tests can vary, and false-negative results are possible, especially during the early stages of infection when antibody levels may be low. In some cases, additional laboratory tests, such as polymerase chain reaction (PCR) testing or culture of the bacteria, may be used to directly detect the presence of the bacterium in blood, joint fluid, or tissues. The interpretation of test results should be done in conjunction with clinical symptoms and exposure history to ensure accurate diagnosis and appropriate treatment of Lyme disease. Consulting with a healthcare professional is crucial for proper testing and interpretation.
The major global suppliers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, T1 Biosystems, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Lyme Disease Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Lyme Disease Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Lyme Disease Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lyme Disease Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Lyme Disease Testing Include:
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
Bio-Rad Laboratories
BioMerieux
T1 Biosystems
Lyme Disease Testing Product Segment Include:
ELISA
Western Blotting
PCR
Others
Lyme Disease Testing Product Application Include:
Hospital and Testing Agency
Personal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Lyme Disease Testing Industry PESTEL Analysis
Chapter 3: Global Lyme Disease Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Lyme Disease Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Lyme Disease Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Lyme Disease Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Lyme Disease Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Lyme Disease Testing market size will reach 259.16 Million USD in 2025 and is projected to reach 408.32 Million USD by 2032, with a CAGR of 6.71% (2025-2032). Notably, the China Lyme Disease Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Lyme disease testing refers to the diagnostic procedures used to detect the presence of Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) and the Western blot test. The EIA is typically used as a screening test and if positive or equivocal, the Western blot test is performed to confirm the diagnosis. These tests detect specific antibodies against the Lyme disease bacteria. However, it is essential to note that the accuracy of these tests can vary, and false-negative results are possible, especially during the early stages of infection when antibody levels may be low. In some cases, additional laboratory tests, such as polymerase chain reaction (PCR) testing or culture of the bacteria, may be used to directly detect the presence of the bacterium in blood, joint fluid, or tissues. The interpretation of test results should be done in conjunction with clinical symptoms and exposure history to ensure accurate diagnosis and appropriate treatment of Lyme disease. Consulting with a healthcare professional is crucial for proper testing and interpretation.
The major global suppliers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, T1 Biosystems, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Lyme Disease Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Lyme Disease Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Lyme Disease Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lyme Disease Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Lyme Disease Testing Include:
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
Bio-Rad Laboratories
BioMerieux
T1 Biosystems
Lyme Disease Testing Product Segment Include:
ELISA
Western Blotting
PCR
Others
Lyme Disease Testing Product Application Include:
Hospital and Testing Agency
Personal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Lyme Disease Testing Industry PESTEL Analysis
Chapter 3: Global Lyme Disease Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Lyme Disease Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Lyme Disease Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Lyme Disease Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Lyme Disease Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Lyme Disease Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Lyme Disease Testing Product by Type
- 1.2.1 ELISA
- 1.2.2 Western Blotting
- 1.2.3 PCR
- 1.2.4 Others
- 1.3 Lyme Disease Testing Product by Application
- 1.3.1 Hospital and Testing Agency
- 1.3.2 Personal
- 1.4 Global Lyme Disease Testing Market Size Analysis (2020-2032)
- 1.5 Lyme Disease Testing Market Development Status and Trends
- 1.5.1 Lyme Disease Testing Industry Development Status Analysis
- 1.5.2 Lyme Disease Testing Industry Development Trends Analysis
- 2 Lyme Disease Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Lyme Disease Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Lyme Disease Testing Market Analysis by Country
- 4.1 Global Lyme Disease Testing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Lyme Disease Testing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Lyme Disease Testing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Lyme Disease Testing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Lyme Disease Testing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Lyme Disease Testing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Lyme Disease Testing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Lyme Disease Testing Market Analysis by Type
- 6.1 Global Lyme Disease Testing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Lyme Disease Testing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Quidel Corporation
- 7.1.1 Quidel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Quidel Corporation Lyme Disease Testing Product Portfolio
- 7.1.3 Quidel Corporation Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Roche Holding AG
- 7.2.1 Roche Holding AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Roche Holding AG Lyme Disease Testing Product Portfolio
- 7.2.3 Roche Holding AG Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Fujirebio(H.U. Group Holdings)
- 7.3.1 Fujirebio(H.U. Group Holdings) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio
- 7.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 ZEUS Scientific
- 7.4.1 ZEUS Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 ZEUS Scientific Lyme Disease Testing Product Portfolio
- 7.4.3 ZEUS Scientific Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 IGeneX
- 7.5.1 IGeneX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 IGeneX Lyme Disease Testing Product Portfolio
- 7.5.3 IGeneX Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Thermo Fisher Scientific
- 7.6.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Thermo Fisher Scientific Lyme Disease Testing Product Portfolio
- 7.6.3 Thermo Fisher Scientific Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Everlywell
- 7.7.1 Everlywell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Everlywell Lyme Disease Testing Product Portfolio
- 7.7.3 Everlywell Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Oxford Immunotec Global PLC(PerkinElmer)
- 7.8.1 Oxford Immunotec Global PLC(PerkinElmer) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio
- 7.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Bio-Rad Laboratories
- 7.9.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Bio-Rad Laboratories Lyme Disease Testing Product Portfolio
- 7.9.3 Bio-Rad Laboratories Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 BioMerieux
- 7.10.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 BioMerieux Lyme Disease Testing Product Portfolio
- 7.10.3 BioMerieux Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 T1 Biosystems
- 7.11.1 T1 Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 T1 Biosystems Lyme Disease Testing Product Portfolio
- 7.11.3 T1 Biosystems Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Lyme Disease Testing Industry Chain Analysis
- 8.2 Lyme Disease Testing Product Downstream Application Analysis
- 8.2.1 Global Lyme Disease Testing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Lyme Disease Testing Revenue and Forecast by Application (2020-2032)
- 8.3 Lyme Disease Testing Typical Downstream Customers
- 8.4 Lyme Disease Testing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
